Stock Screener App

Frei -

Installieren

4.265

1.27% -0.055

Arbutus Biopharma Corp (ABUS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	95.07% 0.529	10.74	1.764	1.574	1.339
Operating Expenses	0.68% 9.188	9.251	27.46	15.51	22.78
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	0.68% 9.188	9.251	27.46	15.51	22.78
Operating Income/Loss	681.92% -8.659	1.488	-25.70	-13.93	-21.44
Nonoperating Income/Loss	11.40% 0.917	1.035	1.173	1.401	1.723
Income/Loss From Continuing Operations Before Tax	79.03% 0.529	2.523	-24.53	1.574	1.339
Income/Loss From Continuing Operations After Tax	406.86% -7.742	2.523	-24.53	-12.53	-19.72
Net Income/Loss	406.86% -7.742	2.523	-24.53	-12.53	-19.72
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.12% 191.78	191.55	190.71	1.3641	189.00
Diluted Average Shares	0.32% 191.78	192.40	190.71	-367.06	189.00
Basic Earnings Per Share	500.00% -0.04	0.01	-0.13	-0.07	-0.10
Diluted Earnings Per Share	500.00% -0.04	0.01	-0.13	-0.07	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters